InsiderDB
Sign inStart free trial

Sen. John Boozman bought DexCom (DXCM)

Sen. John Boozman (R-AR) · $1K–$15K · traded Jan 26, 2026

Transaction
Bought
Amount
$1K–$15K
Owner
Joint
Traded
Jan 26, 2026
Disclosed
Feb 15, 2026
Days to disclose
20
Asset type
Stock
As filed
Dexcom Inc
Industry
Medical - Devices · Healthcare
Official filing ↗All of Boozman's tradesAll Congress trades in DXCM

Other trades in this filing

All of Boozman's trades →

Recent Congress trades in DXCM

Company context for DXCM

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. DXCMLobbying report·Lobbying disclosures

    DXCM: third_quarter 2026 lobbying report

    General representation. Legislative and regulatory issues related to policies and payments for continuous glucose monitoring

    Public: Oct 20, 2026, 1:07 PM EDTOriginal source ↗
  2. DXCMLobbying report·Lobbying disclosures

    DXCM: third_quarter 2026 lobbying report

    Issues related to global supply chains Issues related to the Administration's Executive Orders CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking CGM Coverage policies Issues related to breakthrough technology

    Public: Oct 20, 2026, 11:00 AM EDTOriginal source ↗
  3. DXCMLobbying report·Lobbying disclosures

    DXCM: third_quarter 2026 lobbying report

    Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors.

    Public: Oct 20, 2026, 10:03 AM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.